Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #5350
Reference
Drug alert 09/2014
Name
Drug alert class 4 no 9: caution in use [Wockhardt UK Ltd - Amoxicillin 250, 500mg and 1g powder for solution for injection]
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
Description
Wockhardt UK Ltd has received reports of extravasation and injection site reactions in neonates and infants (below 1 year old). As a precaution Wockhardt UK Ltd are asking all healthcare professionals treating neonates and infants not to use Wockhardt Amoxicillin Sodium Powder for Solution for Injection (all batches) in such patients until further notice, while the company investigates.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Pharmacy and Medicines Division, Finance, e-Health and Pharmaceuticals Directorate, St Andrew's House, Regent Road, Edinburgh, EH1 3DG.
Contact Phone
Created
2014-07-09 00:00:00
Click to go back to homepage